Picking Up The Pieces In Stem Cell Therapy – Seeking Alpha
FierceBiotech |
Picking Up The Pieces In Stem Cell Therapy
Seeking Alpha Anyone with the fixed idea that stem cells are of no use in heart failure would have found little to dissuade them in two presentations at the European Society of Cardiology meeting in Rome on Sunday. Celyad’s (OTC:CLYYF) phase III trial Chart-1 was … CardioCell stem cells ‘improve well-being’ of heart failure patientsFierceBiotech CardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells …PR Newswire (press release) |
FierceBiotech |
CardioCell stem cells ‘improve well-being’ of heart failure patients
FierceBiotech After Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver–and over the weekend posted broadly positive data, but questions, and the need for more clinical … CardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells …PR Newswire (press release) |
Crux: Covering all things Catholic |
Bush has been vindicated on stem cell decision
Crux: Covering all things Catholic A brief science backgrounder: Despite public confusion, stem cells are not embryos; they are the types of cells that can differentiate into one or more of the types of cells of an organism’s body. Because of this, medical researchers have long been … |
|
Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results
TCTMD (registration) ROME, Italy—Another international cardiology meeting, another chance to peer glumly at some small studies with soft endpoints attempting to demonstrate a benefit of stem cells in cardiac regeneration. Two such studies were presented back-to-back this … |